title: A discriminating screening is necessary to ascertain EVI1 expression by RT-PCR in malignant cells from the myeloid lineage without 3q26 rearrangement.
authors.forename: D
authors.initials: D
authors.lastname: Zoccola
authors.forename: L
authors.initials: L
authors.lastname: Legros
authors.forename: P
authors.initials: P
authors.lastname: Cassuto
authors.forename: J G
authors.initials: JG
authors.lastname: Fuzibet
authors.forename: G
authors.initials: G
authors.lastname: Nucifora
authors.forename: S D
authors.initials: SD
authors.lastname: Raynaud
mesh_terms: D002893:Chromosomes, Human, Pair 3 / Q000235:genetics*; D004268:DNA-Binding Proteins / Q000032:analysis / Q000235:genetics*; D015321:Gene Rearrangement; D006801:Humans; D000074008:MDS1 and EVI1 Complex Locus Protein; D009190:Myelodysplastic Syndromes / Q000175:diagnosis / Q000235:genetics / Q000473:pathology*; D009363:Neoplasm Proteins / Q000032:analysis / Q000235:genetics; D011519:Proto-Oncogenes; D012334:RNA, Neoplasm / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods* / Q000592:standards; D012680:Sensitivity and Specificity; D014157:Transcription Factors
chemical_list: D004268:DNA-Binding Proteins; D000074008:MDS1 and EVI1 Complex Locus Protein; C063575:MECOM protein, human; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D014157:Transcription Factors